Writing
Tagged “quality-systems”
6 pieces tagged “quality-systems”, across articles and the blog.
-
What stands between you and a sterility failure
A working list of the controls that keep sterile product sterile, sorted by class, with how each one fails and what FDA has said about it in warning letters issued during 2026.
-
The investigation they should have run
A reconstruction built on one public warning letter: recurring sterility failures blamed on operators, an airflow problem found by the regulator instead, and a step by step account of who you would actually need to talk to, in what order, to reach the real cause.
-
Human error is not a root cause
Inadequate investigation is one of the most consistently cited findings in FDA inspections, and the problem is rarely that firms do not investigate. A walk through the mechanism stage by stage, the decisions each stage forces, and the defects that get records sent back.
-
Harmonisation is a business strategy, not an afterthought
Growing companies treat FDA, EU and local requirements as three different languages. They are closer than they look, and building to the highest standard first is cheaper than retrofitting.
-
The cleanroom is the easy part
Asked how long it takes to go from nothing to GMP production, a lot of people answer three to six months. That is the answer to a different question.
-
AI is coming to the GMP quality system. Understanding has to come first.
FDA has a planned guidance on AI and machine learning in pharmaceutical manufacturing. Having evaluated process analytical technology from the inside, I think the hard part is not the model. It is the signature underneath it.